These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19550388)

  • 1. Fibromyalgic syndromes: could growth hormone therapy be beneficial?
    Cuatrecasas G
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():529-33. PubMed ID: 19550388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?
    Cuatrecasas G; Alegre C; Casanueva FF
    Pituitary; 2014 Jun; 17(3):277-83. PubMed ID: 23568565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone perturbations in fibromyalgia: a review.
    Jones KD; Deodhar P; Lorentzen A; Bennett RM; Deodhar AA
    Semin Arthritis Rheum; 2007 Jun; 36(6):357-79. PubMed ID: 17224178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone replacement throughout life: insights into age-related responses to treatment.
    Clayton P; Gleeson H; Monson J; Popovic V; Shalet SM; Christiansen JS
    Growth Horm IGF Res; 2007 Oct; 17(5):369-82. PubMed ID: 17560153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental syndromes: growth hormone deficiency and treatment.
    Mazzanti L; Tamburrino F; Bergamaschi R; Scarano E; Montanari F; Torella M; Ballarini E; Cicognani A
    Endocr Dev; 2009; 14():114-34. PubMed ID: 19293579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study.
    Cuatrecasas G; Riudavets C; Güell MA; Nadal A
    BMC Musculoskelet Disord; 2007 Nov; 8():119. PubMed ID: 18053120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of quality of life in patients with growth hormone deficiency.
    Webb SM
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Customizing treatment of chronic fatigue syndrome and fibromyalgia: the role of perpetuating factors.
    Van Houdenhove B; Luyten P
    Psychosomatics; 2008; 49(6):470-7. PubMed ID: 19122123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Considerations of growth hormone treatment during the transition from adolescence to adulthood].
    Ranke MB; Wallaschofski H
    Dtsch Med Wochenschr; 2009 May; 134(21):1117-20. PubMed ID: 19437377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical management of growth hormone therapy in adults.
    Salvatori R
    Manag Care; 2009 Aug; 18(8 Suppl 6):10-6. PubMed ID: 19760984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormones and osteoporosis update. Growth hormone and bone].
    Tanaka H
    Clin Calcium; 2009 Jul; 19(7):984-9. PubMed ID: 19567995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on epidemiology, etiology, and diagnosis of adult growth hormone deficiency.
    Prodam F; Pagano L; Corneli G; Golisano G; Belcastro S; Busti A; Gasco V; Beccuti G; Grottoli S; Di Somma C; Colao A; Ghigo E; Aimaretti G
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):6-11. PubMed ID: 19020378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is milnacipran effective in treating pain in patients with fibromyalgia?
    Simon LS
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):126-7. PubMed ID: 16932669
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality of life in congenital, untreated, lifetime isolated growth hormone deficiency.
    Barbosa JA; Salvatori R; Oliveira CR; Pereira RM; Farias CT; Britto AV; Farias NT; Blackford A; Aguiar-Oliveira MH
    Psychoneuroendocrinology; 2009 Jul; 34(6):894-900. PubMed ID: 19181452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypopituitary control and complications study (HypoCCS): a decade of an outcomes assessment observational study.
    Lamberts SW
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):2-5. PubMed ID: 19020377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult growth hormone deficiency (GHD): an established diagnosis?
    Attanasio AF
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):27-32. PubMed ID: 19020382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of current growth hormone treatments and future therapies.
    Ross R
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):48-51. PubMed ID: 19020386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
    Martin DD; Schweizer R; Schönau E; Binder G; Ranke MB
    Horm Res; 2009; 72(1):38-45. PubMed ID: 19571558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone-resistant syndromes: long-term follow-up.
    Chernausek SD
    Endocr Dev; 2009; 14():135-42. PubMed ID: 19293580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label study adding creatine monohydrate to ongoing medical regimens in patients with the fibromyalgia syndrome.
    Leader A; Amital D; Rubinow A; Amital H
    Ann N Y Acad Sci; 2009 Sep; 1173():829-36. PubMed ID: 19758235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.